v3.26.1
Collaboration Agreement - Additional Information (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2025
USD ($)
Jul. 31, 2025
USD ($)
Oct. 31, 2023
USD ($)
Program
Timepoint
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Collaboration revenue       $ 13,374 $ 9,626 $ 21,587 $ 19,045
Future collaboration-related payments received           10,000  
Option, License and Collaboration Agreement              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Accounts receivable from collaboration           800  
Option, License and Collaboration Agreement | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Collaboration revenue       13,400 $ 9,600 21,600 19,000
Adjusted collaboration revenue from revisions to estimated costs       5,100   5,100  
Proceeds received in collaboration agreement     $ 100,000        
Collaboration term     12 years        
Number of timepoints of program | Timepoint     2        
Percentage cover of research and development costs     40.00%        
Percentage share of profits and operating loss for products     40.00%        
Number of fellow-contributed programs | Program     2        
Contract liability/deferred revenue       54,400   54,400  
Reimbursable expenses       $ 0     $ 0
Non-refundable payment received           10,000  
Option, License and Collaboration Agreement | Minimum | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Threshold payment of opt-in fee     $ 45,000        
Option, License and Collaboration Agreement | Maximum | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Threshold payment of opt-in fee     125,000        
Reimburse agreed amount   $ 1,500          
Option, License and Collaboration Agreement | Regulatory and Commercial Milestones | Maximum | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Potential milestone payments     330,000        
Seventh Year of Collaboration Agreement | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Potential proceeds from collaboration extension fees     $ 75,000        
HPI Program License | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Proceeds received in collaboration agreement $ 35,000            
Percentage share of profits and operating loss for products 40.00%            
Proceeds from option fee $ 45,000            
Revenue recognized           $ 35,000  
HPI Program License | Regulatory and Commercial Milestones | Maximum | Gilead Sciences, Inc.              
Research And Development Arrangement Contract To Perform For Others [Line Items]              
Potential milestone payments $ 330,000